{"id":"https://openalex.org/W1969922010","doi":"https://doi.org/10.1055/s-2004-832668","title":"Mechanisms of Relapse Prevention in Schizophrenia","display_name":"Mechanisms of Relapse Prevention in Schizophrenia","alternate_titles":[],"publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W1969922010","doi":"https://doi.org/10.1055/s-2004-832668","mag":"1969922010","pmid":"https://pubmed.ncbi.nlm.nih.gov/15546066"},"language":"en","primary_location":{"id":"doi:10.1055/s-2004-832668","doi":"https://doi.org/10.1055/s-2004-832668","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2004-832668","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1969922010"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108009774","display_name":"Norbert M\u00fcller","orcid":"https://orcid.org/0000-0001-6653-9103","observed_orcids":["https://orcid.org/0000-0001-6653-9103"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"N. M\u00fcller","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy, Ludwig-Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany. norbert.mueller@med.uni-muenchen.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany. norbert.mueller@med.uni-muenchen.de","institution_ids":["https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5108009774"],"corresponding_institution_ids":["https://openalex.org/I8204097"],"apc_list":null,"apc_paid":null,"fwci":1.3107,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.78183873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"37","issue":null,"first_page":"141","last_page":"147"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.996999979019165},{"id":"https://openalex.org/keywords/relapse-risk-factors","display_name":"relapse risk factors","score":0.7979999780654907},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8899999856948853},{"id":"https://openalex.org/keywords/classical-antipsychotics","display_name":"classical antipsychotics","score":0.8669999837875366},{"id":"https://openalex.org/keywords/antipsychotic-withdrawal","display_name":"antipsychotic withdrawal","score":0.9300000071525574},{"id":"https://openalex.org/keywords/expressed-emotion","display_name":"expressed emotion","score":0.5649999976158142},{"id":"https://openalex.org/keywords/stressful-life-events","display_name":"life events","score":0.9599999785423279},{"id":"https://openalex.org/keywords/stress","display_name":"stress","score":0.9240000247955322},{"id":"https://openalex.org/keywords/serotonergic-neurotransmission","display_name":"serotonergic neurotransmission","score":0.8180000185966492},{"id":"https://openalex.org/keywords/dopaminergic-neurotransmission","display_name":"dopamine signaling","score":0.9850000143051147},{"id":"https://openalex.org/keywords/noradrenergic-transmission","display_name":"noradrenergic neurotransmission","score":0.9950000047683716},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7059999704360962},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.9380000233650208},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.7149999737739563},{"id":"https://openalex.org/keywords/incomplete-remission","display_name":"incomplete remission","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.7646994590759277},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7044318318367004},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6012721061706543},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5802512168884277},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5554935932159424},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5308469533920288},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.46639129519462585},{"id":"https://openalex.org/C2781089641","wikidata":"https://www.wikidata.org/wiki/Q7310684","display_name":"Relapse prevention","level":2,"score":0.45085611939430237},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4268912672996521},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.41511809825897217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3565276265144348},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3342691659927368},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29763200879096985},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2357030212879181},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.1392103135585785},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06788572669029236}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007239","descriptor_name":"Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2004-832668","doi":"https://doi.org/10.1055/s-2004-832668","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2004-832668","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:15546066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15546066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019144775","https://openalex.org/W4230589919","https://openalex.org/W1981838182","https://openalex.org/W1953092902","https://openalex.org/W2050173051","https://openalex.org/W2043833687","https://openalex.org/W2297080432","https://openalex.org/W2084320881","https://openalex.org/W2163657807","https://openalex.org/W2466098810"],"abstract_inverted_index":{"INTRODUCTION:":[0],"A":[1],"relapse":[2,61,81,86,107,129,157,229],"can":[3],"be":[4],"expected":[5],"in":[6,16,92,106,191],"70":[7,18],"%":[8,19],"of":[9,20,26,40,55,82,95,109,133,152,156,160,198,220,228,238],"patients":[10,21],"after":[11,29,62,158],"the":[12,27,30,69,73,83,93,113,131,196,236,239],"first":[13,31],"schizophrenic":[14,41,64,153,216,240],"episode;":[15],"parallel":[17],"show":[22],"an":[23,149,211],"incomplete":[24],"remission":[25],"disorder":[28,77],"episode.":[32],"This":[33],"includes":[34],"a":[35,52,60,63,89,128,181,189],"cognitive":[36],"decline":[37,50],"and":[38,51,145,167,174,183,195],"persistence":[39],"negative":[42],"symptoms,":[43],"often":[44],"associated":[45,179],"with":[46,79,180],"social":[47,49],"disabilities,":[48],"worsened":[53],"quality":[54],"life.":[56],"The":[57,123],"risk":[58,74,125,151],"for":[59,75,127],"episode":[65],"remains":[66],"increased":[67,150],"throughout":[68],"patient's":[70],"lifetime.":[71],"Moreover,":[72],"chronic":[76],"increases":[78],"every":[80],"patient.":[84],"Therefore":[85],"prevention":[87,108],"is":[88,130],"primary":[90],"focus":[91],"treatment":[94],"schizophrenia.":[96],"METHODS:":[97],"Studies":[98,155],"point":[99],"out":[100],"that":[101,164],"atypical":[102],"antipsychotics":[103],"have":[104,202,210],"advantages":[105],"schizophrenia":[110],"compared":[111],"to":[112,148,206,209],"\"classical\"":[114],"antipsychotics,":[115],"although":[116],"comparative":[117],"studies":[118,222],"are":[119,170,178,223,242],"still":[120],"lacking.":[121],"RESULTS:":[122],"main":[124],"factor":[126],"withdrawal":[132,159],"antipsychotic":[134,161],"medication.":[135],"Nonbiological":[136],"factors":[137],"such":[138],"as":[139],"high-expressed":[140],"emotions,":[141],"adverse":[142],"life":[143],"events":[144],"stress":[146],"contribute":[147],"relapse.":[154,217],"medication":[162],"revealed":[163],"noradrenergic,":[165],"serotonergic,":[166],"dopaminergic":[168,176],"neurotransmission":[169,177,187],"involved,":[171],"low":[172],"serotonergic":[173],"high":[175,185],"relapse,":[182],"possibly":[184],"noradrenergic":[186],"plays":[188],"role":[190],"short-term":[192],"relapses.":[193],"Inflammation":[194],"activation":[197],"certain":[199],"cytokines,":[200],"which":[201],"rarely":[203],"been":[204],"studied":[205],"date,":[207],"seem":[208],"even":[212],"higher":[213],"impact":[214],"on":[215],"Methodological":[218],"aspects":[219],"these":[221],"discussed.":[224],"CONCLUSION:":[225],"Biological":[226],"mechanisms":[227,237],"may":[230],"not":[231],"become":[232],"fully":[233],"elucidated":[234],"before":[235],"pathophysiology":[241],"clarified.":[243]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1969922010","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
